TradingKey

Más Datos de DaVita Inc Compañía

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

Información de la empresa

Símbolo de cotizaciónDVA

Nombre de la empresaDaVita Inc

Fecha de salida a bolsaOct 31, 1995

Fundada en1994

Director ejecutivoMr. Javier J. Rodriguez

Número de empleados76000

Tipo de seguridadOrdinary Share

Fin del año fiscalOct 31

Dirección2000 16th St

CiudadDENVER

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal80202-5117

Teléfono13105362668

Sitio Webhttps://www.davita.com/

Símbolo de cotizaciónDVA

Fecha de salida a bolsaOct 31, 1995

Fundada en1994

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

837.84K

-4.28%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

101.00K

+8.83%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

66.98K

+12.40%

Ms. Pamela M. Arway

Independent Chair of the Board

25.58K

+1.38%

Mr. David P. Maughan

Chief Operating Officer - Davita Kidney Care

20.58K

-84.60%

Mr. Christopher Michael (Chris) Berry

Chief Accounting Officer

15.96K

+31.62%

Mr. James O. Hearty

Chief Compliance Officer

14.28K

-14.14%

Ms. Phyllis R. Yale

Independent Director

13.20K

+2.71%

Ms. Barbara J. Desoer

Independent Director

12.66K

+2.83%

Dr. Gregory J. Moore, M.D., Ph.D.

Independent Director

6.45K

+5.70%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

837.84K

-4.28%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

101.00K

+8.83%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

66.98K

+12.40%

Ms. Pamela M. Arway

Independent Chair of the Board

25.58K

+1.38%

Mr. David P. Maughan

Chief Operating Officer - Davita Kidney Care

20.58K

-84.60%

Mr. Christopher Michael (Chris) Berry

Chief Accounting Officer

15.96K

+31.62%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Patient service - Medicare and Medicare Advantage

1.61B

49.91%

Patient service - Commercial

1.01B

31.42%

Patient service - Other government

286.49M

8.89%

Patient service - Medicaid and Managed Medicaid

206.51M

6.41%

Other - Medicare and Medicare Advantage

98.95M

3.07%

Other

9.85M

0.31%

Sin datos

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Patient service - Medicare and Medicare Advantage

1.61B

49.91%

Patient service - Commercial

1.01B

31.42%

Patient service - Other government

286.49M

8.89%

Patient service - Medicaid and Managed Medicaid

206.51M

6.41%

Other - Medicare and Medicare Advantage

98.95M

3.07%

Other

9.85M

0.31%

Estadísticas de accionistas

Actualizado: mar., 29 de jul

Accionistas

Tipos de accionistas

Accionistas

Proporción

Berkshire Hathaway Inc.

44.76%

The Vanguard Group, Inc.

6.67%

BlackRock Institutional Trust Company, N.A.

3.86%

State Street Global Advisors (US)

2.91%

Weschler (R Ted)

2.89%

Other

38.91%

Accionistas

Proporción

Berkshire Hathaway Inc.

44.76%

The Vanguard Group, Inc.

6.67%

BlackRock Institutional Trust Company, N.A.

3.86%

State Street Global Advisors (US)

2.91%

Weschler (R Ted)

2.89%

Other

38.91%

Tipos de accionistas

Accionistas

Proporción

Holding Company

44.77%

Investment Advisor

27.26%

Investment Advisor/Hedge Fund

13.12%

Individual Investor

4.74%

Hedge Fund

3.31%

Pension Fund

1.70%

Research Firm

1.58%

Bank and Trust

1.05%

Sovereign Wealth Fund

0.08%

Other

2.38%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

1273

73.75M

97.68%

-6.66M

2025Q1

1300

76.19M

99.78%

-5.46M

2024Q4

1260

79.70M

99.28%

-3.76M

2024Q3

1214

80.97M

98.10%

-3.96M

2024Q2

1180

82.28M

96.62%

-4.32M

2024Q1

1166

84.15M

95.98%

-4.07M

2023Q4

1163

84.91M

95.56%

-3.04M

2023Q3

1159

85.40M

93.52%

-3.20M

2023Q2

1164

84.27M

92.30%

-4.64M

2023Q1

1168

84.01M

92.60%

-5.13M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Berkshire Hathaway Inc.

33.80M

44.76%

-1.35M

-3.83%

May 27, 2025

The Vanguard Group, Inc.

5.03M

6.67%

-160.20K

-3.08%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.91M

3.86%

-2.74K

-0.09%

Mar 31, 2025

State Street Global Advisors (US)

2.20M

2.91%

-147.00K

-6.27%

Mar 31, 2025

Weschler (R Ted)

2.18M

2.89%

--

Aug 06, 2024

Invesco Capital Management LLC

1.31M

1.73%

+73.07K

+5.91%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.19M

1.57%

+36.68K

+3.19%

Mar 31, 2025

LSV Asset Management

962.33K

1.27%

-66.10K

-6.43%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

877.32K

1.16%

-25.10K

-2.78%

Mar 31, 2025

Rodriguez (Javier J)

837.84K

1.11%

-37.42K

-4.28%

Mar 31, 2025

ETFs relacionados

Actualizado: hace 5 horas

Nombre

Proporción

Alpha Architect US Quantitative Value ETF

2.05%

Strategas Global Policy Opportunities ETF

1.98%

SPDR S&P Health Care Services ETF

1.97%

Aztlan Global Stock Selection DM SMID ETF

1.78%

Invesco S&P 500 Equal Weight Health Care ETF

1.71%

First Trust Health Care Alphadex Fund

1.65%

Pacer US Small Cap Cash Cows ETF

1.55%

Pacer US Cash Cows Growth ETF

1.43%

iShares U.S. Healthcare Providers ETF

0.93%

Global X Aging Population ETF

0.89%

Alpha Architect US Quantitative Value ETF

Proporción2.05%

Strategas Global Policy Opportunities ETF

Proporción1.98%

SPDR S&P Health Care Services ETF

Proporción1.97%

Aztlan Global Stock Selection DM SMID ETF

Proporción1.78%

Invesco S&P 500 Equal Weight Health Care ETF

Proporción1.71%

First Trust Health Care Alphadex Fund

Proporción1.65%

Pacer US Small Cap Cash Cows ETF

Proporción1.55%

Pacer US Cash Cows Growth ETF

Proporción1.43%

iShares U.S. Healthcare Providers ETF

Proporción0.93%

Global X Aging Population ETF

Proporción0.89%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

DaVita Inc

138.480USD

DaVita Inc

138.480

Descripción general

Compañía

Finanzas